Suchen
Summit Therapeutics Inc
SMMTZur Watchlist hinzufügen
15.420USD
+1.040+7.23%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
11.97BMarktkapitalisierung
VerlustKGV TTM
Aktionärsstatistik
Aktualisiert: Mon, May 11
Aktualisiert: Mon, May 11
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Duggan (Robert William)
73.45%
Baker Bros. Advisors LP
4.69%
Zanganeh (Mahkam)
4.64%
Xia (Yu)
4.13%
Fidelity Management & Research Company LLC
1.72%
Andere
11.37%
Aktionäre
Aktionäre
Anteil
Duggan (Robert William)
73.45%
Baker Bros. Advisors LP
4.69%
Zanganeh (Mahkam)
4.64%
Xia (Yu)
4.13%
Fidelity Management & Research Company LLC
1.72%
Andere
11.37%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
82.64%
Investment Advisor
7.18%
Hedge Fund
5.75%
Investment Advisor/Hedge Fund
2.40%
Research Firm
0.34%
Sovereign Wealth Fund
0.18%
Pension Fund
0.06%
Andere
1.45%
Institutionelle Beteiligung
Aktualisiert: Sun, Apr 5
Aktualisiert: Sun, Apr 5
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
554
122.68M
15.81%
+4.36M
2025Q4
527
105.36M
14.15%
-7.01M
2025Q3
489
101.69M
13.66%
-7.67M
2025Q2
447
727.40M
97.94%
-484.11K
2025Q1
437
723.14M
98.66%
+648.97K
2024Q4
388
717.73M
97.33%
+5.42M
2024Q3
325
708.90M
96.17%
+11.45M
2024Q2
260
692.13M
98.13%
+14.08M
2024Q1
228
669.32M
95.38%
+36.91M
2023Q4
210
620.08M
88.82%
-5.65M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Duggan (Robert William)
570.07M
73.52%
+13.98M
+2.51%
Oct 21, 2025
Baker Bros. Advisors LP
36.39M
4.69%
+2.67M
+7.91%
Dec 31, 2025
Zanganeh (Mahkam)
35.74M
4.61%
+359.73K
+1.02%
Apr 15, 2025
Xia (Yu)
31.52M
4.07%
--
--
Apr 15, 2025
Fidelity Management & Research Company LLC
13.34M
1.72%
+4.42M
+49.58%
Dec 31, 2025
T. Rowe Price Associates, Inc.
9.26M
1.19%
+4.83M
+109.18%
Dec 31, 2025
State Street Investment Management (US)
6.64M
0.86%
+274.43K
+4.31%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.47M
0.83%
+245.16K
+3.94%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Tema Oncology ETF
1.92%
State Street SPDR S&P Biotech ETF
1.57%
ProShares Ultra Nasdaq Biotechnology
1.38%
Invesco Nasdaq Biotechnology ETF
1.36%
First Trust Lunt US Factor Rotation ETF
0.99%
Direxion Daily S&P Biotech Bull 3X Shares
0.96%
Invesco NASDAQ Next Gen 100 ETF
0.77%
Virtus LifeSci Biotech Clinical Trials ETF
0.64%
Pacer WealthShield ETF
0.25%
Goldman Sachs Equal Weight US Large Cap Equity ETF
0.19%
Mehr Anzeigen
Tema Oncology ETF
Anteil1.92%
State Street SPDR S&P Biotech ETF
Anteil1.57%
ProShares Ultra Nasdaq Biotechnology
Anteil1.38%
Invesco Nasdaq Biotechnology ETF
Anteil1.36%
First Trust Lunt US Factor Rotation ETF
Anteil0.99%
Direxion Daily S&P Biotech Bull 3X Shares
Anteil0.96%
Invesco NASDAQ Next Gen 100 ETF
Anteil0.77%
Virtus LifeSci Biotech Clinical Trials ETF
Anteil0.64%
Pacer WealthShield ETF
Anteil0.25%
Goldman Sachs Equal Weight US Large Cap Equity ETF
Anteil0.19%